Penlon ESO 2 Receives CE Mark Approval for the treatment of COVID-19 patients

Penlon today announced that the Company received CE Mark approval for its ESO 2 Emergency Ventilator for the treatment of COVID-19 patients. For the past three months, Penlon has been working as part of the ‘VentilatorChallengeUK’ consortium to mass-produce thousands of ESO 2 Emergency Ventilators for the NHS in the fight against COVID-19. During that period working was going on to ensure that the ESO 2 would be available outside the UK.

Using its ventilation expertise, Penlon rapidly developed the ESO 2 Emergency Ventilator, based on the existing AV-S anaesthesia ventilator platform. The purpose of the ESO 2 is to save lives by ventilating the sickest patients until they are strong enough to be transferred to one of the limited number of ICU ventilators available for recovery.

With international CE certification, the ESO 2 Emergency Ventilator will soon be available through Penlon’s global distribution network.

Mary Ryan, Penlon’s Director Quality Assurance and Regulatory Affairs said:
 

Some thought it could not happen… that changing the intended use of our anaesthesia devices, to support the UK call-to-arms and be at the front line to support those emergency situations with invasive ventilation, during a global pandemic would not be possible. But we did it!

About Penlon

Penlon has been designing, manufacturing and distributing ventilators, vaporizers and anaesthetic machines for 75 years and has a deserved reputation for high quality, reliable products. Recognition for success has come in the form of four Queen’s Awards for Enterprise.